Trouble reading this e-mail? View it in your browser.

28 June 2013
Header image
Highlight of the week

From our blog

The Way Out for Europe: Why Optimism Matters
27 June 2013 by Richard Bergström

Optimism and its utility in the face of the Euro crisis was one of the topics addressed at EFPIA's public conference, Health and Growth – [...] Read more



New President of EFPIA, Christopher A. Viehbacher, Calls for Strengthened Collaboration to Deliver Health and Growth
28 June 2013

Brussels - June 24, 2013 - Christopher A. Viehbacher, Chief Executive Officer of Sanofi, was elected today President of EFPIA, the European Federation of Pharmaceutical Industries and Associations, for a 2-year term.More info. 


Annual Review
28 June 2013

Following its 2013 Annual General Meetings, EFPIA released its Annual Review of 2012 and Outlook for 2013. The Annual Review is issued every year to keep stakeholders and the public at large informed of the fast-moving developments affecting the pharmaceutical industry in Europe. This year's review centres on four main themes: collaboration, growth, patients, and innovation. Collaboration is the key to overcoming the challenges ahead as the pharmaceutical industry seeks to support European growth and improve care for patients through innovation. 

Read more

From our blog

From our blog

Pharmaceutical Companies and Regulators – Who to Trust?
28 June 2013 by Richard Bergström

Some people in the scientific community are struggling to decide whether they can trust pharmaceutical companies and their regulators. Looking at the diversity of media [...] Read more

From our blog

The Nagoya Protocol on Access to Genetic Resources – The Important Issues Behind a Big Name
28 June 2013 by Communication Team

On July 4th, the European Parliament will vote on a regulation to implement The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable [...] Read more



What does Anti-Counterfeiting Mean for the Pharmaceutical Industry?

An interview with Stuart Hurst - Chair of Efpia's Coding & Serialisation Oversight Group (Eli Lilly)

View video

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail